EU Pediatric Drug Rule Produces Mixed Results, Report Says

International Pharmaceutical Regulatory Monitor
A A
An EU regulation meant to boost pediatric drug development has led to more medicines for children since it was adopted, although actual use of new products has not increased at the same pace, a European Commission report said.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor